Literature DB >> 21921118

Dose adjustment of polymyxins for renal insufficiency.

Alexandre P Zavascki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21921118      PMCID： PMC3186980          DOI： 10.1128/AAC.05080-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  6 in total

1.  Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration.

Authors:  Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Timothy C Smeaton; Kingsley Coulthard
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report.

Authors:  Andrea L H Kwa; Kamilia Abdelraouf; Jenny G H Low; Vincent H Tam
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

3.  The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic.

Authors:  Laura S Elias; Daniele Konzen; Juliana M Krebs; Alexandre P Zavascki
Journal:  J Antimicrob Chemother       Date:  2010-08-04       Impact factor: 5.790

4.  Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.

Authors:  Rajesh V Dudhani; John D Turnidge; Kingsley Coulthard; Robert W Milne; Craig R Rayner; Jian Li; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

5.  Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.

Authors:  S M Garonzik; J Li; V Thamlikitkul; D L Paterson; S Shoham; J Jacob; F P Silveira; A Forrest; R L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

6.  Pharmacokinetics of intravenous polymyxin B in critically ill patients.

Authors:  Alexandre P Zavascki; Luciano Z Goldani; Guoying Cao; Silvana V Superti; Larissa Lutz; Afonso L Barth; Fabiano Ramos; Márcio M Boniatti; Roger L Nation; Jian Li
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079
  6 in total
  2 in total

Review 1.  Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections.

Authors:  Haley J Morrill; Jason M Pogue; Keith S Kaye; Kerry L LaPlante
Journal:  Open Forum Infect Dis       Date:  2015-05-05       Impact factor: 3.835

Review 2.  Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence.

Authors:  Suneel Kumar Garg; Omender Singh; Deven Juneja; Niraj Tyagi; Amandeep Singh Khurana; Amit Qamra; Salman Motlekar; Hanmant Barkate
Journal:  Crit Care Res Pract       Date:  2017-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.